Assessment of Efficacy of Carboxytherapy in Management of Skin Aging Through Evaluation of Gene Expression Profile: A 2-Split Randomized Clinical Trial Publisher Pubmed



Bagherani N¹ ; Firooz A² ; Ghanadan A^{3, 8} ; Smoller BR⁴ ; Mirmomeni G⁵ ; Shojaei R⁶ ; Mondanizadeh M⁷ ; Tavoosidana G¹ Show Affiliations
Source: Archives of Dermatological Research Published:2023

Abstract

Skin aging is a continuous and irreversible process which results in impairment of the skin role as barrier against all aggressive exogenous factors. It mainly manifests by photoaging, laxity, sagging, wrinkling, and xerosis. Carboxytherapy is considered as a safe, minimally invasive modality used for rejuvenation, restoration, and recondition of the skin. In the current study, the efficacy of carboxytherapy in the treatment of skin aging was assessed through investigation of gene expression profile for Coll I, Coll III, Coll IV, elastin, FGF, TGF-β1, and VEGF. Our study is a 2-split clinical trial in which carboxytherapy was performed on one side of the abdomen in 15 cases with intrinsically skin aging manifestations weekly for 10 sessions, while the other side of the abdomen was left without treatment. Two weeks after the last session, skin biopsies were taken from both the treated and control sides of the abdomen in order to assess gene expression profile by qRT-PCR. The analysis of gene expression levels for all of Coll I, Coll III, Coll IV, elastin, TGF-β1, FGF and VEGF genes showed a statistically significant difference between the interventional and control groups. The findings for all of these seven genes showed increase in the interventional group, among which Coll IV, VEGF, FGF, and elastin showed the higher mean changes. Our study confirmed the effectiveness of carboxytherapy in treating and reversing the intrinsically aging skin. Clinical Trial Registration Code and Date of Registration: ChiCTR2200055185; 2022/1/2. © 2023, The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.